Tactile Systems Technology (NASDAQ:TCMD - Get Free Report) posted its earnings results on Tuesday. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.31 by $0.09, Zacks reports. The business had revenue of $85.59 million during the quarter, compared to analyst estimates of $85.39 million. Tactile Systems Technology had a return on equity of 9.37% and a net margin of 5.79%. Tactile Systems Technology updated its FY 2025 guidance to EPS.
Tactile Systems Technology Stock Down 2.1 %
Tactile Systems Technology stock traded down $0.33 during mid-day trading on Friday, hitting $15.05. The company had a trading volume of 578,279 shares, compared to its average volume of 330,612. The company has a current ratio of 4.36, a quick ratio of 3.80 and a debt-to-equity ratio of 0.11. The stock's 50 day moving average price is $17.26 and its two-hundred day moving average price is $15.67. Tactile Systems Technology has a 12 month low of $11.12 and a 12 month high of $21.10. The company has a market capitalization of $354.88 million, a PE ratio of 21.50 and a beta of 1.20.
Analysts Set New Price Targets
A number of research firms recently weighed in on TCMD. StockNews.com downgraded Tactile Systems Technology from a "strong-buy" rating to a "buy" rating in a research report on Thursday, January 16th. B. Riley downgraded Tactile Systems Technology from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $23.00 to $18.00 in a research report on Wednesday. BTIG Research downgraded Tactile Systems Technology from a "buy" rating to a "neutral" rating in a research report on Tuesday, November 5th. Finally, Oppenheimer cut Tactile Systems Technology from an "outperform" rating to a "market perform" rating in a research note on Tuesday, November 5th.
View Our Latest Stock Analysis on Tactile Systems Technology
Tactile Systems Technology Company Profile
(
Get Free Report)
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Featured Stories
Before you consider Tactile Systems Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tactile Systems Technology wasn't on the list.
While Tactile Systems Technology currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
